Pancreatic Cancer Research

EditorialJ Immunother Cancer2025

Dual-faced CXCL5 holds the key to unlocking immunotherapy in obese pancreatic cancer.

Journal
J Immunother Cancer
Published
27 August 2025
Citations
0
Type
Editorial
License
cc by-nc

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try